FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156551413> ?p ?o ?g. }

• W2156551413 abstract "HIV integrase inhibitor use is limited by low genetic barrier to resistance and possible cross-resistance among representatives of this class of antiretrovirals. The aim of this study was to analyse integrase sequence variability among antiretroviral treatment naive and experienced patients with no prior integrase inhibitor (InI) exposure and investigate development of the InI drug resistance mutations following the virologic failure of the raltegravir containing regimen. Sequencing of HIV-1 integrase region from plasma samples of 80 integrase treatment naive patients and serial samples from 12 patients with observed virologic failure on raltegravir containing treatment whenever plasma vireamia exceeded >50 copies/ml was performed. Drug resistance mutations were called with Stanford DB database and grouped into major and minor variants. For subtyping bootstrapped phylogenetic analysis was used; Bayesian Monte Carlo Marcov Chain (MCMC) model was implemented to infer on the phylogenetic relationships between the serial sequences from patients failing on raltegravir. Majority of the integrase region sequences were classified as subtype B; the remaining ones being subtype D, C, G, as well as CRF01_AE , CRF02_AG and CRF13_cpx recombinants. No major integrase drug resistance mutations have been observed in InI-treatment naive patients. In 30 (38.5%) cases polymorphic variation with predominance of the E157Q mutation was observed. This mutation was more common among subtype B (26 cases, 54.2%) than non-B sequences (5 cases, 16.7%), p=0.00099, OR: 5.91 (95% CI:1.77-22.63)]. Other variants included L68V, L74IL, T97A, E138D, V151I, R263K. Among 12 (26.1%) raltegravir treated patients treatment failure was observed; major InI drug resistance mutations (G140S, Q148H and N155H, V151I, E92EQ, V151I, G163R) were noted in four of these cases (8.3% of the total InI-treated patients). Time to the development of drug resistance ranged from 2.6 to 16.3 months with mean increase of HIV viral load of 4.34 (95% CI:1.86-6.84) log HIV-RNA copies/ml at the time of emergence of the major mutations. Baseline polymorphisms, including E157Q were not associated with the virologic failure on raltegravir. In InI treatment naive patients polymorphic integrase sequence variation was common, with no major resistance mutants. In the treatment failing patients selection of drug resistance occurred rapidly and followed the typical drug resistance pathways. Preexisting integrase polymorphisms were not associated with the treatment failure." @default.
• W2156551413 created "2016-06-24" @default.
• W2156551413 creator A5001859689 @default.
• W2156551413 creator A5038727368 @default.
• W2156551413 creator A5077077137 @default.
• W2156551413 creator A5082140105 @default.
• W2156551413 date "2012-12-01" @default.
• W2156551413 modified "2023-10-17" @default.
• W2156551413 title "HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland" @default.
• W2156551413 cites W1574214458 @default.
• W2156551413 cites W1846381171 @default.
• W2156551413 cites W1966805526 @default.
• W2156551413 cites W1967390610 @default.
• W2156551413 cites W1969106027 @default.
• W2156551413 cites W1971123619 @default.
• W2156551413 cites W1973227607 @default.
• W2156551413 cites W1983837630 @default.
• W2156551413 cites W1987372627 @default.
• W2156551413 cites W1988062692 @default.
• W2156551413 cites W1994342377 @default.
• W2156551413 cites W1994770156 @default.
• W2156551413 cites W1997880217 @default.
• W2156551413 cites W2000342533 @default.
• W2156551413 cites W2011109728 @default.
• W2156551413 cites W2015339905 @default.
• W2156551413 cites W2017173005 @default.
• W2156551413 cites W2020393959 @default.
• W2156551413 cites W2030854058 @default.
• W2156551413 cites W2037625569 @default.
• W2156551413 cites W2040454460 @default.
• W2156551413 cites W2041921162 @default.
• W2156551413 cites W2042709111 @default.
• W2156551413 cites W2049894560 @default.
• W2156551413 cites W2052287045 @default.
• W2156551413 cites W2055807403 @default.
• W2156551413 cites W2062055614 @default.
• W2156551413 cites W2063321514 @default.
• W2156551413 cites W2064131094 @default.
• W2156551413 cites W2067264613 @default.
• W2156551413 cites W2067682479 @default.
• W2156551413 cites W2072854874 @default.
• W2156551413 cites W2072883794 @default.
• W2156551413 cites W2075052852 @default.
• W2156551413 cites W2078975498 @default.
• W2156551413 cites W2080894400 @default.
• W2156551413 cites W2092178328 @default.
• W2156551413 cites W2094889034 @default.
• W2156551413 cites W2098605123 @default.
• W2156551413 cites W2098990854 @default.
• W2156551413 cites W2106095665 @default.
• W2156551413 cites W2106866317 @default.
• W2156551413 cites W2108497544 @default.
• W2156551413 cites W2110835349 @default.
• W2156551413 cites W2111211467 @default.
• W2156551413 cites W2120611093 @default.
• W2156551413 cites W2124600882 @default.
• W2156551413 cites W2135041676 @default.
• W2156551413 cites W2135430194 @default.
• W2156551413 cites W2137646827 @default.
• W2156551413 cites W2139876724 @default.
• W2156551413 cites W2140333504 @default.
• W2156551413 cites W2143036893 @default.
• W2156551413 cites W2148544227 @default.
• W2156551413 cites W2150504993 @default.
• W2156551413 cites W2153467269 @default.
• W2156551413 cites W2154164013 @default.
• W2156551413 cites W2158670905 @default.
• W2156551413 cites W2161993838 @default.
• W2156551413 cites W2168350753 @default.
• W2156551413 cites W2312243395 @default.
• W2156551413 doi "https://doi.org/10.1186/1471-2334-12-368" @default.
• W2156551413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3547692" @default.
• W2156551413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23259737" @default.
• W2156551413 hasPublicationYear "2012" @default.
• W2156551413 type Work @default.
• W2156551413 sameAs 2156551413 @default.
• W2156551413 citedByCount "16" @default.
• W2156551413 countsByYear W21565514132013 @default.
• W2156551413 countsByYear W21565514132014 @default.
• W2156551413 countsByYear W21565514132015 @default.
• W2156551413 countsByYear W21565514132016 @default.
• W2156551413 countsByYear W21565514132017 @default.
• W2156551413 countsByYear W21565514132018 @default.
• W2156551413 countsByYear W21565514132020 @default.
• W2156551413 countsByYear W21565514132021 @default.
• W2156551413 countsByYear W21565514132022 @default.
• W2156551413 crossrefType "journal-article" @default.
• W2156551413 hasAuthorship W2156551413A5001859689 @default.
• W2156551413 hasAuthorship W2156551413A5038727368 @default.
• W2156551413 hasAuthorship W2156551413A5077077137 @default.
• W2156551413 hasAuthorship W2156551413A5082140105 @default.
• W2156551413 hasBestOaLocation W21565514131 @default.
• W2156551413 hasConcept C104317684 @default.
• W2156551413 hasConcept C114851261 @default.
• W2156551413 hasConcept C142462285 @default.
• W2156551413 hasConcept C14430832 @default.
• W2156551413 hasConcept C156719811 @default.
• W2156551413 hasConcept C159047783 @default.
• W2156551413 hasConcept C2777068322 @default.
• W2156551413 hasConcept C2777302000 @default.

• next